Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATReceivables - Other
Ratios

Lipocine (LPCN) Accumulated Depreciation & Amortization (2016 - 2024)

Lipocine's Accumulated Depreciation & Amortization history spans 10 years, with the latest figure at $1.2 million for Q4 2024.

  • For Q4 2024, Accumulated Depreciation & Amortization rose 3.48% year-over-year to $1.2 million; the TTM value through Dec 2024 reached $1.2 million, up 3.48%, while the annual FY2024 figure was $1.2 million, 3.48% up from the prior year.
  • Accumulated Depreciation & Amortization reached $1.2 million in Q4 2024 per LPCN's latest filing, up from $1.2 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $1.2 million in Q4 2024 to a low of $1.1 million in Q4 2021.
  • Average Accumulated Depreciation & Amortization over 4 years is $1.2 million, with a median of $1.2 million recorded in 2022.
  • Peak YoY movement for Accumulated Depreciation & Amortization: grew 0.83% in 2022, then grew 3.48% in 2024.
  • A 4-year view of Accumulated Depreciation & Amortization shows it stood at $1.1 million in 2021, then increased by 0.83% to $1.2 million in 2022, then rose by 2.48% to $1.2 million in 2023, then grew by 3.48% to $1.2 million in 2024.
  • Per Business Quant, the three most recent readings for LPCN's Accumulated Depreciation & Amortization are $1.2 million (Q4 2024), $1.2 million (Q4 2023), and $1.2 million (Q4 2022).